Fumiaki Shima

574 citations
24 papers · 490 indexed · h-index 13
Topics
RNA Interference and Gene Delivery (14 papers)Immunotherapy and Immune Responses (11 papers)Biopolymer Synthesis and Applications (8 papers)

In The Last Decade

Fumiaki Shima

24 papers receiving 484 citations

Peers

Fumiaki Shima
Comparison fields: 5 of 87
  • Molecular Biology 250
  • Immunology 200
  • Biomedical Engineering 131
  • Biomaterials 102
  • Pharmaceutical Science 56
Replace Myunggi An with:
Myunggi An United States
Kohta Mohri Japan
Sima Rahimian Netherlands
Marijke Dierendonck Belgium
Bhanu Koppolu United States
Eva Zupančič Portugal
Emily C. Gale United States
Siyuan Chen China
Michael Look United States
Xiaoyu Hong China
Fumiaki Shima relative to Myunggi An United States Myunggi An's profile →
Citations per field
00.5×1.5×2.2×
Myunggi An · 1×
Citations per year

Countries citing papers authored by Fumiaki Shima

Since Specialization
Citations

This map shows the geographic impact of Fumiaki Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Shima more than expected).

Fields of papers citing papers by Fumiaki Shima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiaki Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Shima. The network helps show where Fumiaki Shima may publish in the future.

Co-authorship network of co-authors of Fumiaki Shima

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiaki Shima. A scholar is included among the top collaborators of Fumiaki Shima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiaki Shima. Fumiaki Shima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 3
3 4
4 16
5 7
6 23
7 25
8 7
9 5
10 9
11 18
12 12
13 2
14 14
15 58
16 78
17 28
18 7
19 35
20 58

About Fumiaki Shima

Fumiaki Shima is a scholar working on Immunology, Pharmaceutical Science and Biomaterials, having authored 24 papers that have together received 490 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Immunotherapy and Immune Responses (11 papers) and Biopolymer Synthesis and Applications (8 papers). The work is most often cited by research in Immunology (200 citations), Pharmaceutical Science (56 citations) and Biomaterials (102 citations). Fumiaki Shima has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Mitsuru Akashi, Takami Akagi, Tomofumi Uto, Masanori Baba, Masaaki Toyama, Ye Zhu, Martin Moeller, Tadashi Okano, Akihiro Nishiguchi and Yoshiki Sawa. Their work appears in journals such as Biomaterials, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026